EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TP53 and KMT2D mutations associated with worse prognosis in peripheral T‐cell lymphomas

Lingling Wang, Lei Yang, Fangshu Guan, Jing Chen iD, Yuexin Cheng iD, Yuqing Miao, Jingsong He iD, Zhen Cai iD, He Huang, Yi Zhao iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.70027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Lingling Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Lymphoma, T-Cell, Peripheral, Tumor Suppressor Protein p53, Mutation, DNA-Binding Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There are limited studies on mutation profiling for Peripheral T‐cell lymphomas (PTCL) in the Chinese population. We retrospectively analyzed the clinical and genetic landscape of 66 newly diagnosed Chinese patients. Targeted next‐generation sequencing (NGS) was performed for tissues from these patients. At least one mutation was detected in 60 (90.9%) patients, with a median number of 3 (0–7) mutations, and 32 (48.5%) cases detected with more than 4 mutations. The genes with higher mutation frequencies were TET2, RHOA, DNMT3A, IDH2, TP53, STAT3, and KMT2D respectively. When mutant genes are classified by functional group, the most prevalent mutations are related to epigenetics and signal transduction. IPI ≥2, PIT ≥2, and failure to achieve partial remission (PR) were factors for inferior progression‐free survival (PFS) and overall survival (OS). Multivariate analysis showed TP53 was an adverse factor for PFS (HR, 3.523; 95% CI, 1.262–9.835; p = 0.016), and KMT2D was an adverse factor for OS (HR, 10.097; 95% CI, 1.000–101.953; p = 0.048). Mutation profiling could help differentiate distinct types of PTCL and serve as a useful tool for determining treatment options and prognoses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, T-Cell, PeripheralTumor Suppressor Protein p53MutationDNA-Binding ProteinsHumansMaleFemaleMiddle AgedAdultPrognosisAgedRetrospective StudiesYoung AdultNeoplasm ProteinsHigh-Throughput Nucleotide SequencingAdolescentAged, 80 and overBiomarkers, Tumor

Stichwörter der Autor:innen

KMT2DTP53next generation sequencingperipheral T‐cell lymphoma

Substanzen

KMT2D protein, humanTumor Suppressor Protein p53DNA-Binding ProteinsTP53 protein, humanNeoplasm ProteinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Department of Hematology, The First People's Hospital of Yancheng, The Yancheng Clinical College of Xuzhou Medical University, Yancheng, China.
  • Department of Hematology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.

ORCID-Profile: Jing Chen, Yuexin Cheng, Jingsong He, Zhen Cai, Yi Zhao

Förderung

  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Wang, L., Yang, L., Guan, F., Chen, J., Cheng, Y., Miao, Y., He, J., Cai, Z., Huang, H., & Zhao, Y. (2024). TP53 and KMT2D mutations associated with worse prognosis in peripheral T‐cell lymphomas. Cancer Medicine. https://doi.org/10.1002/cam4.70027

Vancouver

Wang L, Yang L, Guan F, Chen J, Cheng Y, Miao Y, et al. TP53 and KMT2D mutations associated with worse prognosis in peripheral T‐cell lymphomas. Cancer Medicine. 2024. doi:10.1002/cam4.70027

BibTeX
@article{Wang2024,
  author = {Wang, Lingling and Yang, Lei and Guan, Fangshu and Chen, Jing and Cheng, Yuexin and Miao, Yuqing and He, Jingsong and Cai, Zhen and Huang, He and Zhao, Yi},
  title = {TP53 and KMT2D mutations associated with worse prognosis in peripheral T‐cell lymphomas},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70027}
}
Kostenlos starten →